Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 54% ± 19% | |
oligodendrocyte precursor cell | 9 studies | 30% ± 14% | |
epithelial cell | 6 studies | 29% ± 17% | |
goblet cell | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 34% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 86% | 384.91 | 282 / 328 | 92% | 54.88 | 163 / 178 |
brain | 95% | 2911.45 | 2504 / 2642 | 82% | 33.83 | 577 / 705 |
stomach | 78% | 2999.50 | 281 / 359 | 98% | 47.82 | 279 / 286 |
intestine | 46% | 836.80 | 442 / 966 | 98% | 50.35 | 519 / 527 |
kidney | 83% | 460.99 | 74 / 89 | 35% | 7.41 | 312 / 901 |
bladder | 33% | 284.43 | 7 / 21 | 76% | 21.41 | 385 / 504 |
esophagus | 34% | 265.29 | 496 / 1445 | 66% | 35.57 | 121 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 91.39 | 1 / 1 |
prostate | 22% | 82.53 | 53 / 245 | 65% | 6.28 | 327 / 502 |
lung | 19% | 75.05 | 112 / 578 | 65% | 21.69 | 754 / 1155 |
skin | 65% | 572.47 | 1167 / 1809 | 2% | 0.51 | 9 / 472 |
tonsil | 0% | 0 | 0 / 0 | 64% | 8.62 | 29 / 45 |
uterus | 1% | 1.64 | 1 / 170 | 55% | 11.20 | 251 / 459 |
thymus | 25% | 85.05 | 166 / 653 | 26% | 2.84 | 159 / 605 |
breast | 9% | 37.70 | 43 / 459 | 42% | 5.56 | 464 / 1118 |
ovary | 0% | 0 | 0 / 180 | 22% | 2.04 | 96 / 430 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.57 | 5 / 29 |
liver | 0% | 0 | 0 / 226 | 13% | 3.50 | 53 / 406 |
adipose | 3% | 16.60 | 38 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 14.26 | 29 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 7.78 | 26 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.14 | 3 / 230 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
spleen | 1% | 2.28 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0032286 | Biological process | central nervous system myelin maintenance |
GO_1904002 | Biological process | regulation of sebum secreting cell proliferation |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0044857 | Biological process | plasma membrane raft organization |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0030258 | Biological process | lipid modification |
GO_0032287 | Biological process | peripheral nervous system myelin maintenance |
GO_0006682 | Biological process | galactosylceramide biosynthetic process |
GO_0042634 | Biological process | regulation of hair cycle |
GO_1904697 | Biological process | regulation of acinar cell proliferation |
GO_0006679 | Biological process | glucosylceramide biosynthetic process |
GO_0001949 | Biological process | sebaceous gland cell differentiation |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0080132 | Molecular function | fatty acid alpha-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FA2H |
Protein name | Fatty acid 2-hydroxylase Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase) (Fatty acid hydroxylase domain-containing protein 1) |
Synonyms | FAAH FAXDC1 |
Description | FUNCTION: Catalyzes the hydroxylation of free fatty acids at the C-2 position to produce 2-hydroxy fatty acids, which are building blocks of sphingolipids and glycosphingolipids common in neural tissue and epidermis . FA2H is stereospecific for the production of (R)-2-hydroxy fatty acids . Plays an essential role in the synthesis of galactosphingolipids of the myelin sheath (By similarity). Responsible for the synthesis of sphingolipids and glycosphingolipids involved in the formation of epidermal lamellar bodies critical for skin permeability barrier . Participates in the synthesis of glycosphingolipids and a fraction of type II wax diesters in sebaceous gland, specifically regulating hair follicle homeostasis (By similarity). Involved in the synthesis of sphingolipids of plasma membrane rafts, controlling lipid raft mobility and trafficking of raft-associated proteins (By similarity). . |
Accessions | J3QS89 ENST00000219368.8 [Q7L5A8-1] ENST00000567683.5 H3BP32 Q7L5A8 ENST00000569949.1 A0A087WVM8 ENST00000618933.1 |